Published in Hepatitis Weekly, October 23rd, 2006
"Patients with recurrent hepatitis C after liver transplantation usually have a high viral load and are generally resistant to interferon (IFN)-alpha 2b plus ribavirin (RBV) therapy. However, it remains unclear whether pretreatment viral titer determines the effectiveness of combination therapy, especially in patients with a high viral load.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly